Supplementary Table 4 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
收藏数据链接：
官方服务：
资源简介：
Supplementary Table 4. Impact of clinical, genomic features on time to treatment discontinuation for HER2 directed therapy in the FH-FMI CGDB.
创建时间：
2024-04-15
